Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA completes Wyeth GMP inspection

Executive Summary

FDA concludes its re-inspection of the Guayama, Puerto Rico manufacturing facility, Wyeth says April 5. The site passed a GMP inspection by EMEA at the end of March; the firm hopes to address FDA's observations in writing. Wyeth predicts the approval of compounds that are awaiting conclusion of the regulatory action will not be delayed (1"The Pink Sheet" March 5, 2007, p. 17)...

You may also be interested in...



Guayama Inspection Delay Unlikely To Impact Launches, Wyeth Says

FDA's inspection of Wyeth's Guayama, Puerto Rico manufacturing facility is taking longer than anticipated, but the firm does not expect the delay to hold up the launches of compounds it has pending at FDA, Chief Financial Officer Kenneth Martin said during a Feb. 28 conference call

US FDA Urges COVID-19 Transmission Risk Mitigation In Cell And Gene Therapy Manufacturing

The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.

COVID-19: US Acted To Beat Other Countries To Next 1.25M Doses Of Regeneron Cocktail

Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.

UsernamePublicRestriction

Register

LL043624

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel